Sponsor:
Cylene Pharmaceuticals
Code:
NCT00891280
Conditions
Advanced Solid Tumors
Breast Cancer
Inflammatory Breast Cancer
Castleman's Disease
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CX-4945 oral formulation
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Cylene Pharmaceuticals on 2011-06-15.